Notably, we found that the shallow deletion of KAT2B gene was associated with the survival status of CCA patients, as higher proportion of KAT2B gene shallow deletion was detected in the CCA tissues from deceased patients (89%) when compared with that from living patients (61%) (Fig. 2C). Here, KAT2B is linked to cholangiocarcinoma.